📇 Rhumatologue ·
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
1 raison identifiée
Référence presse grand public
Cité 3 fois dans les médias — pédagogie reconnue
✨ Génération du profil synthétique IA en cours…
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Low initial KCO predicts rapid FEV1 decline in pulmonary lymphangioleiomyomatosis
2004ArticleRespiratory Medicine
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
📰 Le Télégramme · 22/06/2017
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxNc2JSN2FMeHlGTjVHMDNyNjNJMkY4a3hsTWhPc3N2TE1BVC1ONmRqajRUYk9VYjBsUVBCam5CVE1zUEVxbVNtVXRDV0FwRG52bnhMZm53UDlZMHhYbkZLR3MwR1hQazVwaTZlUEhRTUU1YUlVSWhpTTB1MGN6U0NOemZONU1aSnA1NEJyU3pkWHk3eTJWRHFPUWM2YW5rQUVNUklWbzlKOW5qWjQ?oc=5" target="_bla
📰 Actu.fr · 21/09/2016
<a href="https://news.google.com/rss/articles/CBMi9AFBVV95cUxNWFFzMERMNnNHZDNTZHhzQnViOHpsMF9iejFRWGstSWRzbXJrZ2ZpLTZqajUtZll5SnhnRmt6OUg3NUtXc3M3aVBlY1g3UVZzZHJfaklzUFBvQ2t6Q2tkVmRPMWNCbGhvOHEtcTFwZmxTXzc4a1F0dGxOak5WRVR2YllIUmVQOHNVX2d1ZzhrdG1YX1laMjJsS0xyMUpQMjUzam9HcTNMOHQtZXZqLWhzMi1KUFJIOVo5ak
📰 Le Télégramme · 01/12/2017
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxPM0VSUjdweFozNV9Cb0hzdW43VFNFLUM2LTVaby1WQkp3ei04TWhNOFJJdkZTckVURGdLOXZUOENBWFZ6MkxxNjVkUVQzRXZNcnpFUGhkSjR1Z05YNmVGZTh1LV82ZVpodkdicy15NW03NUNFU1FZQXc4YmtWZmJ4YTlpUXotbmFHa3Q2X2Yxb083bEZWNGNnbjJ5U2hUSEdkSUNVYVVrTmIzaE50YnRVUy1yWU0zeE52an
Respiratory medicine · 2004
The American review of respiratory disease · 1989
Abstract Neopterin is a metabolite of guanosine-triphosphate, released in vitro by macrophages under the control of gamma-interferon and described as a marker of T cell activation in vivo. We have compared the urinary neopterin/creatinine ratio (µmol/mol) in patients with pulmonary sarcoidosis (n = 66), interstitial lung diseases other than sarcoidosis (nonsarcoid ILD, n = 35), and 45 normal control subjects. For the sarcoid population as a whole, urinary neopterin was higher (496 ± 52 µmol/mol [mean ± SEM]) than in control subjects (126 ± 5 µmol/mol) (p &lt; 0.001). In patients with nonsarcoid ILD, urinary neopterin was frequently higher in granulomatous and/or lymphoproliferative diseases (hypersensitivity pneumonitis, tuberculosis, primitive Sjögren's syndrome, and malignant lymphomas) (781 ± 193 [µmol/mol, n = 10) but remained normal in other types of nonsarcoid ILD ([163 ± 14 µmol/mol, n = 25]: histiocytosis X, idiopathic pulmonary fibrosis, lung collagen-vascular diseases, diffuse neoplasms, pneumoconiosis; p &lt; 0.001 compared with sarcoidosis). We have also evaluated the relationship between urinary neopterin and the clinical or biologic markers currently used to assess sarcoidosis: alveolar lymphocytosis in lavage fluid (ALY), 67-gallium scan semiquantitative index (67Ga), or serum angiotensin-converting enzyme (SACE). Sarcoid patients with the highest urinary neopterin were those in whom mean values of these markers were the highest (p &lt; 0.05, all comparisons). Patients with positive markers (i.e., either clinical expression of sarcoidosis-ALY &gt; 30%-67Ga &gt; 20-SACE &gt; 60 U/ml) had significantly higher urinary neopterin levels than did other sarcoid patients (p &lt; 0.05, all comparisons). Moreover, urinary neopterin values correlated significantly with the number of positive markers found in each of the 42 patients in whom all measurements were made and exhibited the best sensitivity in predicting abnormalities of those markers. Preliminary data concerning the evolution of 22 sarcoid patients over a period of 11 ± 1 months suggest that urinary neopterin levels could reflect the progression of sarcoidosis at least when the disease improves. These data suggest that measurement of urinary neopterin, which is simple to perform, noninvasive, and inexpensive, can take place in diagnostic strategies for dealing with interstitial lung diseases and can be helpful for the management of patients with pulmonary sarcoidosis.
Lymphatic research and biology · 2010
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Lymphatic research and biology · 2010 · Journal Article
Nurok M, Eslick I, Carvalho CR, Costabel U, et al.
The American review of respiratory disease · 1989 · Journal Article
Lacronique J, Auzeby A, Valeyre D, Traore BM, et al.
Revue de pneumologie clinique · 1988 · Case Reports
Lacronique J, Clerici C
Respiratory medicine · 2004 · Journal Article
Lazor R, Valeyre D, Lacronique J, Wallaert B, et al.